drugset / Trial / NCT01068964
Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will evaluate the safety and efficacy of once daily administered 0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution compared with once daily administered 0.03% Bimatoprost Ophthalmic Solution and once daily administered 0.5% Timolol Ophthalmic Solution concurrently in patients with open-angle glaucoma or ocular hypertension
Timeline
- Start
- 2010-02-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution | Unknown | 0.03 % | Other |
| Subject | 0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution | Unknown | 0.5 % | Other |
| Comparator | Bimatoprost | Other / unclassified | 0.03 % | Other |
| Comparator | Timolol | Other / unclassified | 0.5 % | Other |